In‐depth immune profiling of peripheral blood mononuclear cells in patients with pancreatic ductal adenocarcinoma reveals discriminative immune subpopulations
Cancer Science · 2024
DOI: 10.1111/cas.16147 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Science, 2024. Verfasst von Ernesto Rodriguez und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Cell Biology and Immunology, Amsterdam UMC, VU University Amsterdam, Amsterdam, The Netherlands. Hauptthemen laut MEDLINE: Carcinoma, Pancreatic Ductal, Pancreatic Neoplasms, Leukocytes, Mononuclear. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Research Council, Immunoshape, Associazione Italiana per la Ricerca sul Cancro.
Abstract (Originalsprache)
Pancreatic ductal adenocarcinoma (PDAC) has a dismal prognosis with a 5‐year survival of less than 10%. More knowledge of the immune response developed in patients with PDAC is pivotal to develop better combination immune therapies to improve clinical outcome. In this study, we used mass cytometry time‐of‐flight to undertake an in‐depth characterization of PBMCs from patients with PDAC and examine the differences with healthy controls and patients with benign diseases of the biliary system or pancreas. Peripheral blood mononuclear cells from patients with PDAC or benign disease are characterized by the increase of pro‐inflammatory cells, as CD86 + classical monocytes and memory T cells expressing CCR6 + and CXCR3 + , associated with T helper 1 (Th1) and Th17 immune responses, respectively. However, PBMCs from patients with PDAC present also an increase of CD39 + regulatory T cells and CCR4 + CCR6 − CXCR3 − memory T cells, suggesting Th2 and regulatory responses. Concluding, our results show PDAC develops a multifaceted immunity, where a proinflammatory component is accompanied by regulatory responses, which could inhibit potential antitumor mechanisms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Cell Biology and Immunology, Amsterdam UMC, VU University Amsterdam, Amsterdam, The Netherlands.
- Amsterdam Institute for Infection and Immunity, Cancer Immunology, Amsterdam, The Netherlands.
- Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, The Netherlands.
- Department of Surgery, Amsterdam UMC, VU University Amsterdam, Amsterdam, The Netherlands.
- Department of Medical Oncology, Amsterdam UMC, VU University Amsterdam, Amsterdam, The Netherlands.
- Cancer Pharmacology Lab, AIRC Start-Up Unit, Fondazione Pisana per la Scienza, Pisa, Italy.
ORCID-Profile: Eline S Zwart, Alsya A Affandi
Förderung
- European Research Council
- Immunoshape
- Associazione Italiana per la Ricerca sul Cancro
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek
- Bennink Foundation
- Cancer Center Amsterdam Foundation
Zitieren
APA
Rodriguez, E., Zwart, E. S., Affandi, A. A., Verhoeff, J., de Kok, M., Boyd, L. N. C., Meijer, L. L., Le Large, T. Y. S., Olesek, K., Giovannetti, E., García-Vallejo, J. J., Mebius, R. E., van Kooyk, Y., & Kazemier, G. (2024). In‐depth immune profiling of peripheral blood mononuclear cells in patients with pancreatic ductal adenocarcinoma reveals discriminative immune subpopulations. Cancer Science. https://doi.org/10.1111/cas.16147
Vancouver
Rodriguez E, Zwart ES, Affandi AA, Verhoeff J, de Kok M, Boyd LNC, et al. In‐depth immune profiling of peripheral blood mononuclear cells in patients with pancreatic ductal adenocarcinoma reveals discriminative immune subpopulations. Cancer Science. 2024. doi:10.1111/cas.16147
BibTeX
@article{Rodriguez2024,
author = {Rodriguez, Ernesto and Zwart, Eline S and Affandi, Alsya A and Verhoeff, Jan and de Kok, Mike and Boyd, Lenka N C and Meijer, Laura L and Le Large, Tessa Y S and Olesek, Katarzyna and Giovannetti, Elisa and García-Vallejo, Juan J and Mebius, Reina E and van Kooyk, Yvette and Kazemier, Geert},
title = {In‐depth immune profiling of peripheral blood mononuclear cells in patients with pancreatic ductal adenocarcinoma reveals discriminative immune subpopulations},
journal = {Cancer Science},
year = {2024},
doi = {10.1111/cas.16147}
}
EUVIMED